NCT02002611View on ClinicalTrials.gov

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

May 31, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Lobeglitazone

DRUG

Warfarin

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY